Partners Group Holding’s Insmed INSM Stock Holding History

Partners Group Holding’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-15,578	Closed	-$429K	–	47
2020 Q2	$429K	Buy	+15,578	New	+$369K	0.05%	43

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Partners Group Holding's INSM Position: Q3 2020 in Review

Partners Group Holding sold out of Insmed (INSM) in Q3 2020, closing a stake of 15,578 shares — an estimated $429K sold.

Partners Group Holding first reported a position in INSM in Q2 2020 and held it in 1 quarter. The position peaked at $429K in Q2 2020. 200 funds tracked by Wall St. Rank hold INSM as of Q3 2020.

Partners Group Holding reported no remaining Insmed position as of Q3 2020 after selling out during the quarter.
Partners Group Holding sold 15,578 Insmed shares in Q3 2020, an estimated $429K.
Partners Group Holding first reported a position in Insmed in Q2 2020 and held it in 1 quarter.
Partners Group Holding's Insmed position peaked at $429K in Q2 2020.
200 funds tracked by Wall St. Rank held Insmed as of Q3 2020.

Based on Partners Group Holding's 13F filing for Q3 2020, filed 12 Nov 2020.